×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

COVID-19 and the effect on cardiovascular diseases, CV clinical trials and CV outcome trials

April 28, 2020

For clinical researchers involved with COVID-19, understanding its impact on cardiovascular homeostasis and the underlying pathophysiology is essential. In this article, Dr. Lazar Mandinov, Sr. Medical Director at Parexel, outlines the most significant current evidence and uncertainties, and provides practical guidance for conducting clinical trials related to COVID-19.

Previous Article
COVID-19 Vaccine Development - Part 1: Progress and Challenges
COVID-19 Vaccine Development - Part 1: Progress and Challenges

The enormous societal impact and global mortality, now over 150,000, that has resulted from the rapid sprea...

Next Article
How SARS-CoV-2 Will Catalyze Decentralized Testing
How SARS-CoV-2 Will Catalyze Decentralized Testing

About the Authors Arushi AgarwalArushi Agarwal joined the Health Advances team in 2011...